Medacta Group S.A.
MEDGF
Other OTC83.91
USD
- -
- -
ISIN
CH0468525222
Return %
Stock
S&P500
1Y
- -
26.53
3Y
- -
76.60
5Y
-32.06
80.11
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- CEO
- Francesco Siccardi
- Full Time Employees
- 1,907
- Sector
- Healthcare
- Industry
- Medical - Devices
- Address
- Strada Regina, 34 Castel San Pietro Switzerland 6874
- IPO Date
- May 29, 2019
- Website
- medacta.com
- Similar Companies
- Business
- Medacta Group SA develops, manufactures and distributes orthopedic and neurosurgical medical devices worldwide. The company offers hip products including the MPACT 3D Metal Monocer, Versafitcup DM, Sensitin DM Converter, cemented cups, Versacem, Apricot and Native systems; knee products including the AMIS-K Long, Quadra-R, Amistem, Quadra, Masterloc and Minimax systems; shoulder products; spine products such as Mecta-C stand-alone and system, M.U.S.T. Mini, Mectalif anterior, M.U.S.T. SI, Myspine, Myspine S2AI and Nextar Spine implants along with enabling technologies like Myspine Cervical; extremity and sports medicine solutions including hemiarthroplasty components, bipolar heads, endo heads and patient-optimized pathway tools; as well as personalized 3D planning, patient-matched technology, verification tools, instruments, cleaning products, decontamination and sterilization products, woodpecker motors, Chana reamer handles and instrument trays. Medacta operates in over 60 countries across Europe, North America, Asia-Pacific, Latin America, the Middle East and Africa, targeting surgeons and healthcare professionals in joint replacement, sports medicine and spine surgery segments. Founded in 1999 by Dr. Alberto Siccardi and headquartered in Castel San Pietro, Switzerland, the company emphasizes minimally invasive surgery, personalized solutions and sustainability through collaborations with surgeons and investments in R&D. In March 2025, Medacta acquired Parcus Medical, a US-based sports medicine and arthroscopy provider, integrating its portfolio for shoulder, knee, hip and foot & ankle procedures into the Sportsmed business line; this included Parcus' Florida manufacturing site for vertical integration and expanded US sales access in over 45 countries, accelerating growth in the ambulatory surgical center market.
Medacta Group SA (MEDGF) Q4 2025 Earnings Call Transcript
Medacta Group SA (MEDGF) Q4 2025 Sales/Trading Call Transcript